0001140361-14-040662.txt : 20141107
0001140361-14-040662.hdr.sgml : 20141107
20141107134220
ACCESSION NUMBER: 0001140361-14-040662
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141105
FILED AS OF DATE: 20141107
DATE AS OF CHANGE: 20141107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoey Timothy
CENTRAL INDEX KEY: 0001553333
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 141203909
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2014-11-05
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001553333
Hoey Timothy
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
SVP, Cancer Biology
Common Stock
2014-11-05
4
M
0
2500
1.43
A
52445
D
Common Stock
2014-11-05
4
S
0
2500
19.5064
D
49945
D
Stock Option (Right to Buy)
1.43
2014-11-05
4
M
0
2500
0.00
D
2017-01-10
Common Stock
2500
42763
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2013.
Includes 602 shares acquired under the Issuer's Employee Stock Purchase Plan on August 29, 2014.
This transaction was executed in multiple trades in prices ranging from $19.15 to $19.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The option is fully vested and exercisable, subject to a limitation of 175,438 shares that can be issued to a single grantee in a 12-month period upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan.
/s/ Yvonne Li, Attorney-in-Fact for Timothy Hoey
2014-11-07